Gennova has been working on self-amplifying mRNA vaccine. mRNA vaccines use body’s machinery to make antigenic protein rather ...

Bengaluru, along with Hyderabad, NCR Delhi, and Chennai, is a major hub for these centers, making up 74% of the new ones.

Please find enclosed herewith a Press Release titled Gennova Advances Pathbreaking AI-Enhanced saRNA Vaccine for one of the deadliest known viruses in collaboration with CEPI by Gennova ...

Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharmaceuticals Ltd., is advancing the development of a pathbreaking self-amplifying mRNA (saRNA) vaccine against the deadly Nipah virus. Read also: ...

The company said it has decided to price its version of Risdiplam product at Rs 15,900, and further added that it intends to offer discount to certain deserving patients through its patient access ...

(Image Credits: Pixabay) Gennova Biopharmaceuticals Ltd. on Tuesday announced that it is partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), a subsidiary of Emcure ...

The affordability of economic housing projects in Pune is likely to take a hit as the Maharashtra government has increased the ready-reckoner rates, further hampering the growth of the real estate ...

Pune: Emcure Pharmaceuticals Ltd. subsidiary Gennova Biopharma ceuticals Ltd., is advancing the development of a pathbreaking self-amplifying mRNA (saRNA) vaccine against the deadly Nipah virus. This ...

Pune-based Gennova Biopharmaceuticals Ltd will develop a self-amplifying mRNA vaccine candidate against the deadly Nipah virus. The critical initiative is supported by an expanded partnership with the ...

Gennova Biopharmaceuticals Limited, a subsidiary of Emcure Pharmaceuticals, on Tuesday said it has signed a new agreement with the Coalition for Epidemic Preparedness Innovations (CEPI ...

Gennova Biopharmaceuticals, a subsidiary of Emcure Pharmaceuticals, has announced a collaboration with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of a ...